PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $615M
- YoY, 2025
- −9.0%
- 5-year CAGR
- +17.1%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $615M | −9.0% |
| 2024 | $675M | +100.6% |
| 2023 | $337M | +56.2% |
| 2022 | $216M | −28.1% |
| 2021 | $300M | +7.3% |
| 2020 | $280M | +249.7% |
| 2019 | $80M | −28.9% |
| 2018 | $113M | −6.7% |
| 2017 | $121M | +37.8% |
| 2016 | $88M | — |
| 2015 | −$27M | — |
| 2014 | −$13M | — |